Search Within

Craig Steven Sauter

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (98)
  2. Journal Article (63)
  3. Research Letter (3)
Groups
  1. Bone Marrow Transplant (164)
  2. Center for Hematologic Malignancies (164)
  3. Department of Medicine (164)
  4. Epidemiology and Biostatistics (164)
  5. Hematologic Malignancies, Division of (164)
  6. Biostatistics Service (158)

More Groups

People
  1. Miguel-Angel Perales (129)
  2. Sean Devlin (127)
  3. Sergio Giralt (123)
  4. Parastoo Dahi (83)
  5. Doris Ponce (71)
  6. Molly Maloy (71)

More People

Years
  1. 2023 (9)
  2. 2022 (15)
  3. 2021 (11)
  4. 2020 (26)
  5. 2019 (18)
  6. 2018 (16)

More Years

Publications
  1. Blood (49)
  2. Biology of Blood and Marrow Transplantation (47)
  3. Bone Marrow Transplantation (13)
  4. Blood Advances (12)
  5. Transplantation and Cellular Therapy (11)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (61)
  2. Elsevier Inc. (59)
  3. Nature Publishing Group (17)
  4. Taylor & Francis Group (5)
  5. Wiley Blackwell (5)
  6. American Society of Clinical Oncology (4)

More Publishers

Results (164)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Journal Article

    Hobbs, G. S.; Kaur, N.; Hilden, P.; Ponce, D.; Cho, C.; Castro-Malaspina, H. R.; Giralt, S.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months
    Journal Article

    Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous hematopoietic stem cell transplant
    Meeting Abstract

    Gil-Cupello, M.; Shah, G. L.; Maloy, M. A.; Goldman, D. A.; Devlin, S. M.; Matasar, M. J.; Giralt, S. A.; Sauter, C. S.; Moskowitz, C. H.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save